Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-25 @ 3:39 AM
Study NCT ID:
NCT01311050
Status:
UNKNOWN
Last Update Posted:
2011-12-13
First Post:
2011-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Sponsor:
King Faisal Specialist Hospital & Research Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RAC# 2081-068
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None